AIMS: To compare serum lipid, lipoprotein and apolipoprotein concentrations during and six to 12 months after pregnancy in control and diabetic women. METHODS: The serum lipid, lipoprotein and apolipoprotein concentrations were measured in 20 women with gestational diabetes mellitus (GDM) and 22 women with normal glucose tolerance (controls) during the third trimester of pregnancy and six to 12 months after delivery. RESULTS: During pregnancy the women with GDM had higher serum triglyceride (mean (95% confidence interval (CI)), 2.91 (2.22-3.51) v 2.1 (1.75-2.52)) but lower low density lipoprotein (LDL) cholesterol concentrations compared with controls (mean (SD), 3.08 (1.2) v 4.01 (1.1). Total cholesterol, high density lipoprotein (HDL) cholesterol and apolipoprotein concentrations were not significantly different between the two groups. After pregnancy, total cholesterol, HDL cholesterol, triglyceride, and apolipoprotein A1 and B decreased in a parallel manner, resulting in lower concentrations, comparable between the two groups. LDL cholesterol concentrations decreased after pregnancy in the controls (mean (SD), 4.01 (1.1) v 2.69 (0.6)) but not in those with GDM (3.08 (1.2) v 2.72 (0.7)). The change in lipid concentrations was not related to change in weight. CONCLUSION: Development of diabetes during pregnancy induces a state of dyslipidaemia characterised by elevated triglyceride concentrations, as seen in other insulin resistance states. However, GDM seems to blunt the increase in LDL cholesterol during pregnancy and this requires further investigation. Whether the changes in lipoprotein metabolism in GDM are significant for the health status of the mother and the foetus requires further study.
AIMS: To compare serum lipid, lipoprotein and apolipoprotein concentrations during and six to 12 months after pregnancy in control and diabeticwomen. METHODS: The serum lipid, lipoprotein and apolipoprotein concentrations were measured in 20 women with gestational diabetes mellitus (GDM) and 22 women with normal glucose tolerance (controls) during the third trimester of pregnancy and six to 12 months after delivery. RESULTS: During pregnancy the women with GDM had higher serum triglyceride (mean (95% confidence interval (CI)), 2.91 (2.22-3.51) v 2.1 (1.75-2.52)) but lower low density lipoprotein (LDL) cholesterol concentrations compared with controls (mean (SD), 3.08 (1.2) v 4.01 (1.1). Total cholesterol, high density lipoprotein (HDL) cholesterol and apolipoprotein concentrations were not significantly different between the two groups. After pregnancy, total cholesterol, HDL cholesterol, triglyceride, and apolipoprotein A1 and B decreased in a parallel manner, resulting in lower concentrations, comparable between the two groups. LDL cholesterol concentrations decreased after pregnancy in the controls (mean (SD), 4.01 (1.1) v 2.69 (0.6)) but not in those with GDM (3.08 (1.2) v 2.72 (0.7)). The change in lipid concentrations was not related to change in weight. CONCLUSION: Development of diabetes during pregnancy induces a state of dyslipidaemia characterised by elevated triglyceride concentrations, as seen in other insulin resistance states. However, GDM seems to blunt the increase in LDL cholesterol during pregnancy and this requires further investigation. Whether the changes in lipoprotein metabolism in GDM are significant for the health status of the mother and the foetus requires further study.
Authors: Erica P Gunderson; Charles P Quesenberry; David R Jacobs; Juanran Feng; Cora E Lewis; Stephen Sidney Journal: Am J Epidemiol Date: 2010-10-07 Impact factor: 4.897
Authors: K Krzyzanowska; L Zemany; W Krugluger; G H Schernthaner; F Mittermayer; C Schnack; R Rahman; J Brix; B B Kahn; G Schernthaner Journal: Diabetologia Date: 2008-04-25 Impact factor: 10.122
Authors: Helena E Miettinen; Kristiina Rönö; Saila Koivusalo; Beata Stach-Lempinen; Maritta Pöyhönen-Alho; Johan G Eriksson; Timo P Hiltunen; Helena Gylling Journal: J Lipid Res Date: 2014-10-09 Impact factor: 5.922
Authors: Liangjian Lu; Albert Koulman; Clive J Petry; Benjamin Jenkins; Lee Matthews; Ieuan A Hughes; Carlo L Acerini; Ken K Ong; David B Dunger Journal: Diabetes Care Date: 2016-10-04 Impact factor: 19.112
Authors: Christian S Göbl; Ammon Handisurya; Katharina Klein; Latife Bozkurt; Anton Luger; Dagmar Bancher-Todesca; Alexandra Kautzky-Willer Journal: Diabetes Care Date: 2010-06-02 Impact factor: 17.152
Authors: Helen L Barrett; Marloes Dekker Nitert; Lee Jones; Peter O'Rourke; Karin Lust; Kathryn L Gatford; Miles J De Blasio; Suzette Coat; Julie A Owens; William M Hague; H David McIntyre; Leonie Callaway; Janet Rowan Journal: Diabetes Care Date: 2013-02-07 Impact factor: 19.112